These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 16943794

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
    Hellstrom WJ, Gittelman M, Jarow J, Steidle C, McMurray J, Talley D, Watts S, Mitchell CL, McGill JM.
    Eur Urol; 2008 May; 53(5):1058-65. PubMed ID: 17945409
    [Abstract] [Full Text] [Related]

  • 29. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
    Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group.
    Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
    [Abstract] [Full Text] [Related]

  • 30. Treatment preferences in men with erectile dysfunction: an open label study in Korean men switching from sildenafil citrate to tadalafil.
    Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS.
    Asian J Androl; 2007 Nov; 9(6):760-70. PubMed ID: 17968461
    [Abstract] [Full Text] [Related]

  • 31. The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non-randomised, open-label clinical study.
    Fugl-Meyer KS, Stothard D, Belger M, Toll A, Berglund O, Eliasson T, Fugl-Meyer AR.
    Int J Clin Pract; 2006 Nov; 60(11):1386-93. PubMed ID: 17073836
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Observation of safety and efficacy of tadalafil for men with erectile dysfunction].
    Zhu XW, Li FY, Fang JJ.
    Zhonghua Nan Ke Xue; 2006 May; 12(5):421-3, 427. PubMed ID: 16755872
    [Abstract] [Full Text] [Related]

  • 35. A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men.
    Eaton CB, Liu YL, Mittleman MA, Miner M, Glasser DB, Rimm EB.
    Int J Impot Res; 2007 May; 19(2):218-25. PubMed ID: 16915303
    [Abstract] [Full Text] [Related]

  • 36. Endothelial apoptosis decrease following tadalafil administration in patients with arterial ED does not last after its discontinuation.
    La Vignera S, Condorelli RA, Vicari E, D'Agata R, Calogero AE.
    Int J Impot Res; 2011 May; 23(5):200-5. PubMed ID: 21677665
    [Abstract] [Full Text] [Related]

  • 37. The treatment of erectile dysfunction study: focus on treatment satisfaction of patients and partners.
    Brock G, Chan J, Carrier S, Chan M, Salgado L, Klein AH, Lang C, Horner R, Gutkin S, Dickson R.
    BJU Int; 2007 Feb; 99(2):376-82. PubMed ID: 17155989
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US.
    Rajfer J, Aliotta PJ, Steidle CP, Fitch WP, Zhao Y, Yu A.
    Int J Impot Res; 2007 Feb; 19(1):95-103. PubMed ID: 16871272
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.